Publications by authors named "Rachel McGovern"

Claim this Profile
P
Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.
Katherine J Lepik, Benita Yip, Rachel A McGovern, Erin Ding, Adriana Nohpal

Antivir Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1.
David J H F Knapp, Rachel A McGovern, Art F Y Poon, Xiaoyin Zhong, Dennison Chan

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends in the discontinuation of first-line antiretroviral therapy.
Alejandro Gonzalez-Serna, Keith Chan, Benita Yip, William Chau, Rachel McGovern

J Antimicrob Chemother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early immune adaptation in HIV-1 revealed by population-level approaches.
Eric Martin, Jonathan M Carlson, Anh Q Le, Denis R Chopera, Rachel McGovern

Retrovirology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint.
Rachel A McGovern, Jori Symons, Art F Y Poon, P Richard Harrigan, Steven F L van Lelyveld

J Antimicrob Chemother· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing.
David J H F Knapp, Rachel A McGovern, Winnie Dong, Art F Y Poon, Luke C Swenson

J Clin Microbiol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
Rachel A McGovern, Alexander Thielen, Simon Portsmouth, Theresa Mo, Winnie Dong

J Acquir Immune Defic Syndr· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
Mark A Brockman, Denis R Chopera, Alex Olvera, Chanson J Brumme, Jennifer Sela, Rachel McGovern

J Virol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data.
Art F Y Poon, Rachel A McGovern, Theresa Mo, David J H F Knapp, Bluma Brenner

AIDS· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially.
Alexander Thielen, Thomas Lengauer, Luke C Swenson, Winnie W Y Dong, Rachel A McGovern

Antivir Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypic inference of HIV-1 tropism using population-based sequencing of V3.
Rachel A McGovern, P Richard Harrigan, Luke C Swenson

J Vis Exp· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
Rachel A McGovern, Alexander Thielen, Theresa Mo, Winnie Dong, Conan K Woods

AIDS· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trofile HIV co-receptor usage assay.
Andrew J Low, Rachel A McGovern, P Richard Harrigan

Expert Opin Med Diagn· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Ildiko Antal-Zimanyi, Marc A Bruce, Karen L Leboulluec, Lawrence G Iben, Gail K Mattson, Rachel T McGovern

Eur J Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.
Kevin W Gillman, Mendi A Higgins, Graham S Poindexter, Marc Browning, Wendy J Clarke, Rachel T McGovern

Bioorg Med Chem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements.
Graham S Poindexter, Marc A Bruce, J Guy Breitenbucher, Mendi A Higgins, S-Y Sit, Rachel T McGovern

Bioorg Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a presynaptic 5-HT1A antagonist.
Ronald J Mattson, John D Catt, Charles P Sloan, Qi Gao, Richard B Carter, Rachel McGovern

Bioorg Med Chem Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyridine neuropeptide Y Y(1) receptor antagonists.
Graham S Poindexter, Marc A Bruce, Karen L LeBoulluec, Ivo Monkovic, Scott W Martin, Rachel T McGovern

Bioorg Med Chem Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis